Akero Therapeutics, Inc.
AKRO
$54.20
-$0.70-1.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.05% | 35.10% | 29.30% | 18.88% | 163.29% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 252.70% | 174.34% | 39.51% | 320.75% | 78.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.74% | 37.58% | 29.67% | 20.65% | 162.25% |
|
|
|||||
| Total Current Assets | -21.74% | 37.58% | 29.67% | 20.65% | 162.25% |
| Net Property, Plant & Equipment | -28.45% | -26.41% | -23.25% | -21.88% | -21.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 26.70% | 42.33% | 28.68% | 30.32% | 161.52% |
|
|
|||||
| Total Accounts Payable | -21.42% | 28.26% | 120.21% | 43.94% | 94.68% |
| Total Accrued Expenses | 53.44% | 160.17% | 20.99% | 45.40% | 72.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.99% | -44.25% | 12.30% | 12.24% | 12.18% |
| Total Finance Division Other Current Liabilities | -7.24% | -- | 37.55% | 42.74% | 116.86% |
| Total Other Current Liabilities | -7.24% | -- | 37.55% | 42.74% | 116.86% |
| Total Current Liabilities | 40.25% | 107.83% | 52.18% | 44.31% | 81.43% |
|
|
|||||
| Total Current Liabilities | 40.25% | 107.83% | 52.18% | 44.31% | 81.43% |
| Long-Term Debt | -17.22% | 41.39% | 54.26% | 41.37% | 41.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -39.87% | -35.41% | -31.87% | -28.83% | -26.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 66.29% | 259.26% | 118.28% | 92.94% | 9.88% |
| Total Liabilities | 9.10% | 68.52% | 51.78% | 41.39% | 55.37% |
|
|
|||||
| Common Stock & APIC | 34.32% | 42.03% | 35.35% | 35.20% | 95.33% |
| Retained Earnings | -42.94% | -43.91% | -45.72% | -42.60% | -40.00% |
| Treasury Stock & Other | 1,473.42% | 251.11% | 515.61% | -3.98% | -476.19% |
| Total Common Equity | 28.08% | 40.13% | 26.61% | 29.46% | 176.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 28.08% | 40.13% | 26.61% | 29.46% | 176.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 28.08% | 40.13% | 26.61% | 29.46% | 176.24% |
|
|
|||||